Spravato is the brand name of esketamine, a nasally adminitsered medicine used for the rapid treatment of moderate to severe depression. Spravato was initially released by Johnson & Johnson  in the US at the beginning March 2019. In the UK, it is now a medcine (by Janssen-Cilag) and available from specialist psychiatric prescribers and pharmacies […]